Hair loss treatment may be considered as part of a structured, clinician-guided care plan when appropriate.
Treatment decisions are based on clinical evaluation, medical history, and individual factors.

Minoxidil (Topical or Oral)

Minoxidil is a vasodilator that may be used to support hair growth by improving blood flow to hair follicles and prolonging the growth (anagen) phase of the hair cycle. It may be considered in patients with certain types of hair loss, including androgen-related hair thinning.

How it may help:
• Supports follicular activity
• May slow progression of hair thinning
• May promote regrowth in some individuals

Responses to therapy vary, and consistent use is typically required to maintain effects.

Finasteride (Oral)

Finasteride is a 5-alpha reductase inhibitor that reduces the conversion of testosterone to dihydrotestosterone (DHT), a hormone associated with androgen-related hair loss. It may be considered in appropriate patients to help slow hair loss progression and support hair preservation.

How it may help:
• Reduces DHT levels in the scalp
• May slow or stabilize hair loss
• May support regrowth in some individuals

Use is based on clinical evaluation, and potential risks, benefits, and side effects should be discussed prior to initiation.

GHK-Cu is a copper-binding peptide that may support scalp health, tissue repair, and the follicular environment.

It is a non-hormonal topical solution applied to the scalp and may be incorporated into care plans when clinically appropriate.

How it may help:
• Supports scalp and skin health
• May improve the follicular environment
• May support hair quality and thickness

Evidence for hair regrowth remains limited, and it is generally considered a supportive therapy rather than a primary treatment.

NOTE Not all patients are candidates for treatment. All care is based on medical evaluation and provider judgment.